Method for perfusion decellularization of porcine whole liver and kidney for use as a scaffold for clinical-scale bioengineering engrafts

Background Whole‐organ engineering provides a new alternative source of donor organs for xenotransplantation. Utilization of decellularized whole‐organ scaffolds, which can be created by detergent perfusion, is a strategy for tissue engineering. In this article, our aim is to scale up the decellular...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Xenotransplantation (Københaven) 2015-01, Vol.22 (1), p.48-61
Hauptverfasser: Wang, Yujia, Bao, Ji, Wu, Qiong, Zhou, Yongjie, Li, Yi, Wu, Xiujuan, Shi, Yujun, Li, Li, Bu, Hong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 61
container_issue 1
container_start_page 48
container_title Xenotransplantation (Københaven)
container_volume 22
creator Wang, Yujia
Bao, Ji
Wu, Qiong
Zhou, Yongjie
Li, Yi
Wu, Xiujuan
Shi, Yujun
Li, Li
Bu, Hong
description Background Whole‐organ engineering provides a new alternative source of donor organs for xenotransplantation. Utilization of decellularized whole‐organ scaffolds, which can be created by detergent perfusion, is a strategy for tissue engineering. In this article, our aim is to scale up the decellularization process to human‐sized liver and kidney to generate a decellularized matrix with optimal and stable characteristics on a clinically relevant scale. Methods Whole porcine liver and kidney were decellularized by perfusion using different detergents (1% SDS, 1% Triton X‐100, 1% peracetic acid (PAA), and 1% NaDOC) via the portal vein and renal artery of the liver and kidney, respectively. After rinsing with PBS to remove the detergents, the obtained liver and kidney extracellular matrix (ECM) were processed for histology, residual cellular content analysis, and ECM components evaluation to investigate decellularization efficiency, xenoantigens removal, and ECM preservation. Results The resulting liver and kidney scaffolds in the SDS‐treated group showed the most efficient clearance of cellular components and xenoantigens, including DNA and protein, and preservation of the extracellular matrix composition. In comparison, cell debris was observed in the other decellularized groups that were generated using Triton X‐100, PAA, and NaDOC. Special staining and immunochemistry of the porcine liver and kidney ECMs further confirmed the disrupted three‐dimension ultrastructure of the ECM in the Triton X‐100 and NaDOC groups. Additionally, Triton X‐100 effectively eliminated the residual SDS in the SDS‐treated group, which ensured the scaffolds were not cytotoxic to cells. Thus, we have developed an optimal method that can be scaled up for use with other solid whole organs. Conclusions Our SDS‐perfusion protocol can be used for porcine liver and kidney decellularization to obtain organ scaffolds cleared of cellular material, xenoimmunogens, and preserved vital ECM components.
doi_str_mv 10.1111/xen.12141
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1655520546</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1655520546</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4291-73e365755fb5ddaca04a6a798197d1eb04e2b1b5859ea1cdadcd8214faac50eb3</originalsourceid><addsrcrecordid>eNp1kE1PFTEUhhujkSu68A-YLnUx0M5M52NpEFBEjImGGzfNmfYUKr3ttZ0Rrv-Af20vA-zsps3J8z7peQl5zdkez2f_Bv0eL3nNn5AFr_q-qFjXPyUL1rOuaBqx3CEvUvrFGKtEJ56TnVKUPa8rsSC3X3C8DJqaEOkao5mSDZ5qVOjc5CDavzBuJ8HQdYjKeqTXl8EhdfYPRgpe0yurPW7uDFNCCokCTQqMCW72Kme9VeCKPM3JwQb0F9mE0foLmt8RzJhekmcGXMJX9_cu-XF0-P3gY3H69fjTwfvTQtX500VbYdWIVggzCK1BAauhgbbveN9qjgOrsRz4kPfsEbjSoJXucjcGQAmGQ7VL3s7edQy_J0yjXNm0XRc8hilJ3gghSibqJqPvZlTFkFJEI9fRriBuJGdy27zMzcu75jP75l47DSvUj-RD1RnYn4Fr63Dzf5NcHp49KIs5YdOIN48JiFeyaatWyPOzY1l_OP_8bXlyJH9W_wB2DqAy</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1655520546</pqid></control><display><type>article</type><title>Method for perfusion decellularization of porcine whole liver and kidney for use as a scaffold for clinical-scale bioengineering engrafts</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Wang, Yujia ; Bao, Ji ; Wu, Qiong ; Zhou, Yongjie ; Li, Yi ; Wu, Xiujuan ; Shi, Yujun ; Li, Li ; Bu, Hong</creator><creatorcontrib>Wang, Yujia ; Bao, Ji ; Wu, Qiong ; Zhou, Yongjie ; Li, Yi ; Wu, Xiujuan ; Shi, Yujun ; Li, Li ; Bu, Hong</creatorcontrib><description>Background Whole‐organ engineering provides a new alternative source of donor organs for xenotransplantation. Utilization of decellularized whole‐organ scaffolds, which can be created by detergent perfusion, is a strategy for tissue engineering. In this article, our aim is to scale up the decellularization process to human‐sized liver and kidney to generate a decellularized matrix with optimal and stable characteristics on a clinically relevant scale. Methods Whole porcine liver and kidney were decellularized by perfusion using different detergents (1% SDS, 1% Triton X‐100, 1% peracetic acid (PAA), and 1% NaDOC) via the portal vein and renal artery of the liver and kidney, respectively. After rinsing with PBS to remove the detergents, the obtained liver and kidney extracellular matrix (ECM) were processed for histology, residual cellular content analysis, and ECM components evaluation to investigate decellularization efficiency, xenoantigens removal, and ECM preservation. Results The resulting liver and kidney scaffolds in the SDS‐treated group showed the most efficient clearance of cellular components and xenoantigens, including DNA and protein, and preservation of the extracellular matrix composition. In comparison, cell debris was observed in the other decellularized groups that were generated using Triton X‐100, PAA, and NaDOC. Special staining and immunochemistry of the porcine liver and kidney ECMs further confirmed the disrupted three‐dimension ultrastructure of the ECM in the Triton X‐100 and NaDOC groups. Additionally, Triton X‐100 effectively eliminated the residual SDS in the SDS‐treated group, which ensured the scaffolds were not cytotoxic to cells. Thus, we have developed an optimal method that can be scaled up for use with other solid whole organs. Conclusions Our SDS‐perfusion protocol can be used for porcine liver and kidney decellularization to obtain organ scaffolds cleared of cellular material, xenoimmunogens, and preserved vital ECM components.</description><identifier>ISSN: 0908-665X</identifier><identifier>EISSN: 1399-3089</identifier><identifier>DOI: 10.1111/xen.12141</identifier><identifier>PMID: 25291435</identifier><language>eng</language><publisher>Denmark: Blackwell Publishing Ltd</publisher><subject>Animals ; Basement Membrane - chemistry ; Bioengineering - methods ; decellularization ; Deoxycholic Acid - pharmacology ; Detergents - pharmacology ; DNA - analysis ; extracellular matrix ; Extracellular Matrix - ultrastructure ; Kidney - drug effects ; Kidney - ultrastructure ; Liver - drug effects ; Liver - ultrastructure ; Male ; Membrane Proteins - analysis ; Microscopy, Electron, Scanning ; Octoxynol - pharmacology ; Peracetic Acid - pharmacology ; Perfusion ; porcine ; Portal Vein ; Renal Artery ; Sodium Dodecyl Sulfate - pharmacology ; Swine ; Swine, Miniature - anatomy &amp; histology ; tissue engineering ; Tissue Scaffolds ; xenotransplantation</subject><ispartof>Xenotransplantation (Københaven), 2015-01, Vol.22 (1), p.48-61</ispartof><rights>2014 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4291-73e365755fb5ddaca04a6a798197d1eb04e2b1b5859ea1cdadcd8214faac50eb3</citedby><cites>FETCH-LOGICAL-c4291-73e365755fb5ddaca04a6a798197d1eb04e2b1b5859ea1cdadcd8214faac50eb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fxen.12141$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fxen.12141$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25291435$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Yujia</creatorcontrib><creatorcontrib>Bao, Ji</creatorcontrib><creatorcontrib>Wu, Qiong</creatorcontrib><creatorcontrib>Zhou, Yongjie</creatorcontrib><creatorcontrib>Li, Yi</creatorcontrib><creatorcontrib>Wu, Xiujuan</creatorcontrib><creatorcontrib>Shi, Yujun</creatorcontrib><creatorcontrib>Li, Li</creatorcontrib><creatorcontrib>Bu, Hong</creatorcontrib><title>Method for perfusion decellularization of porcine whole liver and kidney for use as a scaffold for clinical-scale bioengineering engrafts</title><title>Xenotransplantation (Københaven)</title><addtitle>Xenotransplantation</addtitle><description>Background Whole‐organ engineering provides a new alternative source of donor organs for xenotransplantation. Utilization of decellularized whole‐organ scaffolds, which can be created by detergent perfusion, is a strategy for tissue engineering. In this article, our aim is to scale up the decellularization process to human‐sized liver and kidney to generate a decellularized matrix with optimal and stable characteristics on a clinically relevant scale. Methods Whole porcine liver and kidney were decellularized by perfusion using different detergents (1% SDS, 1% Triton X‐100, 1% peracetic acid (PAA), and 1% NaDOC) via the portal vein and renal artery of the liver and kidney, respectively. After rinsing with PBS to remove the detergents, the obtained liver and kidney extracellular matrix (ECM) were processed for histology, residual cellular content analysis, and ECM components evaluation to investigate decellularization efficiency, xenoantigens removal, and ECM preservation. Results The resulting liver and kidney scaffolds in the SDS‐treated group showed the most efficient clearance of cellular components and xenoantigens, including DNA and protein, and preservation of the extracellular matrix composition. In comparison, cell debris was observed in the other decellularized groups that were generated using Triton X‐100, PAA, and NaDOC. Special staining and immunochemistry of the porcine liver and kidney ECMs further confirmed the disrupted three‐dimension ultrastructure of the ECM in the Triton X‐100 and NaDOC groups. Additionally, Triton X‐100 effectively eliminated the residual SDS in the SDS‐treated group, which ensured the scaffolds were not cytotoxic to cells. Thus, we have developed an optimal method that can be scaled up for use with other solid whole organs. Conclusions Our SDS‐perfusion protocol can be used for porcine liver and kidney decellularization to obtain organ scaffolds cleared of cellular material, xenoimmunogens, and preserved vital ECM components.</description><subject>Animals</subject><subject>Basement Membrane - chemistry</subject><subject>Bioengineering - methods</subject><subject>decellularization</subject><subject>Deoxycholic Acid - pharmacology</subject><subject>Detergents - pharmacology</subject><subject>DNA - analysis</subject><subject>extracellular matrix</subject><subject>Extracellular Matrix - ultrastructure</subject><subject>Kidney - drug effects</subject><subject>Kidney - ultrastructure</subject><subject>Liver - drug effects</subject><subject>Liver - ultrastructure</subject><subject>Male</subject><subject>Membrane Proteins - analysis</subject><subject>Microscopy, Electron, Scanning</subject><subject>Octoxynol - pharmacology</subject><subject>Peracetic Acid - pharmacology</subject><subject>Perfusion</subject><subject>porcine</subject><subject>Portal Vein</subject><subject>Renal Artery</subject><subject>Sodium Dodecyl Sulfate - pharmacology</subject><subject>Swine</subject><subject>Swine, Miniature - anatomy &amp; histology</subject><subject>tissue engineering</subject><subject>Tissue Scaffolds</subject><subject>xenotransplantation</subject><issn>0908-665X</issn><issn>1399-3089</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1PFTEUhhujkSu68A-YLnUx0M5M52NpEFBEjImGGzfNmfYUKr3ttZ0Rrv-Af20vA-zsps3J8z7peQl5zdkez2f_Bv0eL3nNn5AFr_q-qFjXPyUL1rOuaBqx3CEvUvrFGKtEJ56TnVKUPa8rsSC3X3C8DJqaEOkao5mSDZ5qVOjc5CDavzBuJ8HQdYjKeqTXl8EhdfYPRgpe0yurPW7uDFNCCokCTQqMCW72Kme9VeCKPM3JwQb0F9mE0foLmt8RzJhekmcGXMJX9_cu-XF0-P3gY3H69fjTwfvTQtX500VbYdWIVggzCK1BAauhgbbveN9qjgOrsRz4kPfsEbjSoJXucjcGQAmGQ7VL3s7edQy_J0yjXNm0XRc8hilJ3gghSibqJqPvZlTFkFJEI9fRriBuJGdy27zMzcu75jP75l47DSvUj-RD1RnYn4Fr63Dzf5NcHp49KIs5YdOIN48JiFeyaatWyPOzY1l_OP_8bXlyJH9W_wB2DqAy</recordid><startdate>201501</startdate><enddate>201501</enddate><creator>Wang, Yujia</creator><creator>Bao, Ji</creator><creator>Wu, Qiong</creator><creator>Zhou, Yongjie</creator><creator>Li, Yi</creator><creator>Wu, Xiujuan</creator><creator>Shi, Yujun</creator><creator>Li, Li</creator><creator>Bu, Hong</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201501</creationdate><title>Method for perfusion decellularization of porcine whole liver and kidney for use as a scaffold for clinical-scale bioengineering engrafts</title><author>Wang, Yujia ; Bao, Ji ; Wu, Qiong ; Zhou, Yongjie ; Li, Yi ; Wu, Xiujuan ; Shi, Yujun ; Li, Li ; Bu, Hong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4291-73e365755fb5ddaca04a6a798197d1eb04e2b1b5859ea1cdadcd8214faac50eb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Basement Membrane - chemistry</topic><topic>Bioengineering - methods</topic><topic>decellularization</topic><topic>Deoxycholic Acid - pharmacology</topic><topic>Detergents - pharmacology</topic><topic>DNA - analysis</topic><topic>extracellular matrix</topic><topic>Extracellular Matrix - ultrastructure</topic><topic>Kidney - drug effects</topic><topic>Kidney - ultrastructure</topic><topic>Liver - drug effects</topic><topic>Liver - ultrastructure</topic><topic>Male</topic><topic>Membrane Proteins - analysis</topic><topic>Microscopy, Electron, Scanning</topic><topic>Octoxynol - pharmacology</topic><topic>Peracetic Acid - pharmacology</topic><topic>Perfusion</topic><topic>porcine</topic><topic>Portal Vein</topic><topic>Renal Artery</topic><topic>Sodium Dodecyl Sulfate - pharmacology</topic><topic>Swine</topic><topic>Swine, Miniature - anatomy &amp; histology</topic><topic>tissue engineering</topic><topic>Tissue Scaffolds</topic><topic>xenotransplantation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Yujia</creatorcontrib><creatorcontrib>Bao, Ji</creatorcontrib><creatorcontrib>Wu, Qiong</creatorcontrib><creatorcontrib>Zhou, Yongjie</creatorcontrib><creatorcontrib>Li, Yi</creatorcontrib><creatorcontrib>Wu, Xiujuan</creatorcontrib><creatorcontrib>Shi, Yujun</creatorcontrib><creatorcontrib>Li, Li</creatorcontrib><creatorcontrib>Bu, Hong</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Xenotransplantation (Københaven)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Yujia</au><au>Bao, Ji</au><au>Wu, Qiong</au><au>Zhou, Yongjie</au><au>Li, Yi</au><au>Wu, Xiujuan</au><au>Shi, Yujun</au><au>Li, Li</au><au>Bu, Hong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Method for perfusion decellularization of porcine whole liver and kidney for use as a scaffold for clinical-scale bioengineering engrafts</atitle><jtitle>Xenotransplantation (Københaven)</jtitle><addtitle>Xenotransplantation</addtitle><date>2015-01</date><risdate>2015</risdate><volume>22</volume><issue>1</issue><spage>48</spage><epage>61</epage><pages>48-61</pages><issn>0908-665X</issn><eissn>1399-3089</eissn><abstract>Background Whole‐organ engineering provides a new alternative source of donor organs for xenotransplantation. Utilization of decellularized whole‐organ scaffolds, which can be created by detergent perfusion, is a strategy for tissue engineering. In this article, our aim is to scale up the decellularization process to human‐sized liver and kidney to generate a decellularized matrix with optimal and stable characteristics on a clinically relevant scale. Methods Whole porcine liver and kidney were decellularized by perfusion using different detergents (1% SDS, 1% Triton X‐100, 1% peracetic acid (PAA), and 1% NaDOC) via the portal vein and renal artery of the liver and kidney, respectively. After rinsing with PBS to remove the detergents, the obtained liver and kidney extracellular matrix (ECM) were processed for histology, residual cellular content analysis, and ECM components evaluation to investigate decellularization efficiency, xenoantigens removal, and ECM preservation. Results The resulting liver and kidney scaffolds in the SDS‐treated group showed the most efficient clearance of cellular components and xenoantigens, including DNA and protein, and preservation of the extracellular matrix composition. In comparison, cell debris was observed in the other decellularized groups that were generated using Triton X‐100, PAA, and NaDOC. Special staining and immunochemistry of the porcine liver and kidney ECMs further confirmed the disrupted three‐dimension ultrastructure of the ECM in the Triton X‐100 and NaDOC groups. Additionally, Triton X‐100 effectively eliminated the residual SDS in the SDS‐treated group, which ensured the scaffolds were not cytotoxic to cells. Thus, we have developed an optimal method that can be scaled up for use with other solid whole organs. Conclusions Our SDS‐perfusion protocol can be used for porcine liver and kidney decellularization to obtain organ scaffolds cleared of cellular material, xenoimmunogens, and preserved vital ECM components.</abstract><cop>Denmark</cop><pub>Blackwell Publishing Ltd</pub><pmid>25291435</pmid><doi>10.1111/xen.12141</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0908-665X
ispartof Xenotransplantation (Københaven), 2015-01, Vol.22 (1), p.48-61
issn 0908-665X
1399-3089
language eng
recordid cdi_proquest_miscellaneous_1655520546
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Animals
Basement Membrane - chemistry
Bioengineering - methods
decellularization
Deoxycholic Acid - pharmacology
Detergents - pharmacology
DNA - analysis
extracellular matrix
Extracellular Matrix - ultrastructure
Kidney - drug effects
Kidney - ultrastructure
Liver - drug effects
Liver - ultrastructure
Male
Membrane Proteins - analysis
Microscopy, Electron, Scanning
Octoxynol - pharmacology
Peracetic Acid - pharmacology
Perfusion
porcine
Portal Vein
Renal Artery
Sodium Dodecyl Sulfate - pharmacology
Swine
Swine, Miniature - anatomy & histology
tissue engineering
Tissue Scaffolds
xenotransplantation
title Method for perfusion decellularization of porcine whole liver and kidney for use as a scaffold for clinical-scale bioengineering engrafts
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T14%3A53%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Method%20for%20perfusion%20decellularization%20of%20porcine%20whole%20liver%20and%20kidney%20for%20use%20as%20a%20scaffold%20for%20clinical-scale%20bioengineering%20engrafts&rft.jtitle=Xenotransplantation%20(K%C3%B8benhaven)&rft.au=Wang,%20Yujia&rft.date=2015-01&rft.volume=22&rft.issue=1&rft.spage=48&rft.epage=61&rft.pages=48-61&rft.issn=0908-665X&rft.eissn=1399-3089&rft_id=info:doi/10.1111/xen.12141&rft_dat=%3Cproquest_cross%3E1655520546%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1655520546&rft_id=info:pmid/25291435&rfr_iscdi=true